Study details
Enrolling now
Continuous Glucose Monitoring in People With Gastroparesis and Diabetes
Samita Garg
NCT IDNCT06046833ClinicalTrials.gov data as of Apr 2026
Target enrollment
50
Study length
about 2.2 years
Ages
18+
Locations
1 site in OH
About this study
This trial is testing a continuous glucose monitor (FreeStyle Libre 3 sensor) to see if it helps manage blood sugar levels in people with gastroparesis and diabetes. Participants will also receive nutritional drinks as part of the treatment.
Based on ClinicalTrials.gov records.
What participants do
- 1.Nutritional drink
- 2.Use FreeStyle Libre 3 continuous glucose monitoring sensor
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Devices
monitoring
Body systems
Endocrinology